Home LiteratureArticle Details
PMID: 3033328 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

Journal of virology ·Vol. 61 ·No. 6 ·1987-06-00 ·Pages 2017-23

Wahren B, Morfeldt-Månsson L, Biberfeld G, Moberg L, Sönnerborg A, Ljungman P, Werner A, Kurth R, Gallo R, Bolognesi D

Abstract

The human immunodeficiency virus (HIV)-specific lymphocyte proliferation response was determined for 40 persons at different stages of HIV infection. The specific response to purified HIV virion antigens from strain HTLV-IIIB was poor, occurred in only 9 of the 40 subjects, was not improved with the addition of interleukin-2, and was more frequent in symptom-free individuals (46%) than in patients with lymphadenopathy syndrome (10%). Reactivity to subcomponent p24 was better than that to whole HIV; reactivity was present in five of six infected persons and increased with the addition of exogenous interleukin-2. Reactivities to subcomponents (g)p41 and gp120 were also measured. This is the first evidence of a specific cell-mediated immune response to HIV antigen in HIV-infected persons. Monkeys immunized with purified HIV or with purified p24 displayed cellular immunoreactivity both to whole HIV and to subcomponents. In contrast to the poor reactivity to HIV antigen, the lymphocytes of the patients had good specific cell proliferation responses to cytomegalovirus and herpes simplex virus challenge and a normal response to the addition of phytohemagglutinin. The results suggest a functional defect in peripheral lymphocytes of some HIV-infected individuals on the basis of their response to whole HIV antigen and a better response to gag protein.

MeSH Terms
AIDS-Related Complex/immunology Acquired Immunodeficiency Syndrome/immunology Adult Animals Antigens, Viral/immunology HIV/immunology HIV Envelope Protein gp120 HIV Envelope Protein gp41 Humans Immunity, Cellular Immunization Interleukin-2/pharmacology Lymphocyte Activation Macaca fascicularis Male Middle Aged Retroviridae Proteins/immunology Retroviridae Proteins, Oncogenic Viral Envelope Proteins/immunology Virion/immunology
Chemicals
Antigens, Viral HIV Envelope Protein gp120 HIV Envelope Protein gp41 Interleukin-2 Retroviridae Proteins Retroviridae Proteins, Oncogenic Viral Envelope Proteins internal protein p24, Human T-lymphotropic virus 2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Wahren B
Morfeldt-Månsson L
Biberfeld G
Moberg L
Sönnerborg A
Ljungman P
Werner A
Kurth R
Gallo R
Bolognesi D
References (40)
40 references, click to expand
  1. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
    N Engl J Med. 1977 Jun 16;296(24):1372-7 PMID: 193008
  2. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Lancet. 1985 Jun 29;1(8444):1480-2 PMID: 2409414
  3. An interchangeable ELISA for cytomegalovirus antigen and antibody.
    J Virol Methods. 1981 Apr;2(5):301-12 PMID: 6262352
  4. T-cell ratios in homosexuals.
    Lancet. 1982 Apr 17;1(8277):908 PMID: 6122124
  5. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
    N Engl J Med. 1982 Jul 1;307(1):7-13 PMID: 6281647
  6. Immunological characterization of homosexual males.
    Cancer Res. 1983 Feb;43(2):897-904 PMID: 6600216
  7. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
    Science. 1983 May 20;220(4599):868-71 PMID: 6189183
  8. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
    J Clin Invest. 1983 Jul;72(1):398-403 PMID: 6308051
  9. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.
    Eur J Immunol. 1983 Oct;13(10):804-9 PMID: 6196203
  10. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
    Science. 1984 May 4;224(4648):497-500 PMID: 6200935
  11. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
    Science. 1984 May 4;224(4648):500-3 PMID: 6200936
  12. Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone.
    Virology. 1984 Mar;133(2):456-9 PMID: 6200990
  13. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.
    Science. 1984 Jul 6;225(4657):59-63 PMID: 6328660
  14. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
    J Clin Immunol. 1984 Jul;4(4):304-11 PMID: 6086703
  15. Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome.
    J Clin Invest. 1984 Aug;74(2):496-506 PMID: 6611354
  16. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Cancer Res. 1985 Jan;45(1):406-10 PMID: 2578099
  17. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  18. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9 PMID: 3872457
  19. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome.
    Am J Med. 1985 Apr;78(4):621-6 PMID: 2984932
  20. Sensitive analytic ELISAs for subclass herpes virus IgG.
    J Virol Methods. 1985 Mar;10(3):203-14 PMID: 2985640
  21. Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS.
    N Engl J Med. 1985 Jun 6;312(23):1517 PMID: 2985997
  22. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.
    N Engl J Med. 1985 Jul 11;313(2):79-84 PMID: 2582258
  23. Suppressor activity of bovine Fc gamma positive cells during a persistent infection with Mycobacterium avium.
    Res Vet Sci. 1985 May;38(3):270-4 PMID: 3160094
  24. Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome.
    J Infect Dis. 1985 Oct;152(4):727-33 PMID: 2413136
  25. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
    Science. 1985 Oct 25;230(4724):453-5 PMID: 2996136
  26. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up.
    Transplantation. 1985 Nov;40(5):515-20 PMID: 2997952
  27. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection.
    J Infect Dis. 1986 Apr;153(4):743-8 PMID: 2936833
  28. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.
    J Gen Virol. 1986 Apr;67 ( Pt 4):719-26 PMID: 3485697
  29. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.
    Science. 1986 May 9;232(4751):727-32 PMID: 3008337
  30. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase.
    J Virol Methods. 1985 Dec;12(3-4):199-208 PMID: 2422193
  31. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
    J Infect Dis. 1986 May;153(5):970-3 PMID: 3009638
  32. Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro.
    J Virol. 1986 Jun;58(3):909-13 PMID: 3009895
  33. Interleukin 1 activity in the acquired immunodeficiency syndrome.
    Scand J Immunol. 1986 Apr;23(4):491-7 PMID: 3486462
  34. Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.
    DNA. 1986 Apr;5(2):93-9 PMID: 3011373
  35. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    J Exp Med. 1986 Jun 1;163(6):1529-38 PMID: 3011949
  36. Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation.
    Blood. 1986 Jul;68(1):108-12 PMID: 3013339
  37. Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection.
    N Engl J Med. 1986 Aug 7;315(6):393-4 PMID: 3016538
  38. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  39. Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus.
    Med Microbiol Immunol. 1987;176(1):13-9 PMID: 3029554
  40. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).
    Virology. 1980 Nov;107(1):13-23 PMID: 6255675
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1987-06-00
Pages
2017-23
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC254211
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]